R C Moon

1.8k total citations
61 papers, 1.5k citations indexed

About

R C Moon is a scholar working on Molecular Biology, Genetics and Pharmacology. According to data from OpenAlex, R C Moon has authored 61 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 27 papers in Genetics and 8 papers in Pharmacology. Recurrent topics in R C Moon's work include Estrogen and related hormone effects (25 papers), Retinoids in leukemia and cellular processes (13 papers) and Inflammatory mediators and NSAID effects (7 papers). R C Moon is often cited by papers focused on Estrogen and related hormone effects (25 papers), Retinoids in leukemia and cellular processes (13 papers) and Inflammatory mediators and NSAID effects (7 papers). R C Moon collaborates with scholars based in United States, Australia and United Kingdom. R C Moon's co-authors include Rajendra G. Mehta, David L. McCormick, Ranjan Mehta, Carol J. Detrisac, Gary J. Kelloff, John M. Pezzuto, Robert M. Moriarty, Clarissa Gerhäuser, Cathy F. Thomas and Peter J. Becci and has published in prestigious journals such as Journal of Clinical Oncology, Blood and JNCI Journal of the National Cancer Institute.

In The Last Decade

R C Moon

60 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
R C Moon United States	22	875	487	283	224	223	61	1.5k
Barry D. Gehm United States	17	937 1.1×	471 1.0×	260 0.9×	173 0.8×	117 0.5×	20	1.8k
Sheryl Phung United States	20	530 0.6×	309 0.6×	269 1.0×	177 0.8×	197 0.9×	32	1.2k
Anders Åström Sweden	25	1.2k 1.4×	391 0.8×	232 0.8×	208 0.9×	139 0.6×	48	1.9k
Margot M. Ip United States	35	1.3k 1.4×	637 1.3×	838 3.0×	110 0.5×	778 3.5×	94	3.3k
Wayne C. Glasgow United States	26	899 1.0×	254 0.5×	155 0.5×	75 0.3×	283 1.3×	46	1.9k
Chi‐Wai Wong China	25	1.1k 1.3×	331 0.7×	195 0.7×	95 0.4×	324 1.5×	49	1.9k
Dominique Bernard-Gallon France	33	1.6k 1.8×	646 1.3×	392 1.4×	198 0.9×	494 2.2×	99	2.5k
George Melnykovych United States	24	959 1.1×	130 0.3×	145 0.5×	76 0.3×	167 0.7×	87	1.4k
Paola Bontempo Italy	22	1.3k 1.5×	759 1.6×	397 1.4×	102 0.5×	180 0.8×	41	2.3k
Seetharaman Balasenthil United States	32	1.6k 1.9×	568 1.2×	837 3.0×	196 0.9×	384 1.7×	66	2.6k

Countries citing papers authored by R C Moon

Since Specialization

Citations

This map shows the geographic impact of R C Moon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R C Moon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R C Moon more than expected).

Fields of papers citing papers by R C Moon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R C Moon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R C Moon. The network helps show where R C Moon may publish in the future.

Co-authorship network of co-authors of R C Moon

This figure shows the co-authorship network connecting the top 25 collaborators of R C Moon. A scholar is included among the top collaborators of R C Moon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R C Moon. R C Moon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Loo, Sun, Nicola Potter, Adam Ivey, et al.. (2024). Pretransplant MRD detection of fusion transcripts is strongly prognostic in KMT2A-rearranged acute myeloid leukemia. Blood. 144(24). 2554–2557. 4 indexed citations

Gills, Joell J., Jerome W. Kosmeder, R C Moon, Daniel D. Lantvit, & John M. Pezzuto. (2005). Effect of Deguelin on UVB-Induced Skin Carcinogenesis. Journal of Chemotherapy. 17(3). 297–301. 9 indexed citations

Christov, Konstantin, R C Moon, Daniel D. Lantvit, et al.. (2004). Prostate intraepithelial neoplasia in Noble rats, a potential intermediate endpoint for chemoprevention studies. European Journal of Cancer. 40(9). 1404–1411. 11 indexed citations

Green, J E, Masaaki Shibata, Etsuko Shibata, et al.. (2001). 2-difluoromethylornithine and dehydroepiandrosterone inhibit mammary tumor progression but not mammary or prostate tumor initiation in C3(1)/SV40 T/t-antigen transgenic mice.. PubMed. 61(20). 7449–55. 44 indexed citations

Cobleigh, Melody, Kambiz Dowlatshahi, Rajendra G. Mehta, et al.. (1993). Phase I/II trial of tamoxifen with or without fenretinide, an analog of vitamin A, in women with metastatic breast cancer.. Journal of Clinical Oncology. 11(3). 474–477. 57 indexed citations

Ratko, Thomas A, Carol J. Detrisac, Rajendra G. Mehta, Gary J. Kelloff, & R C Moon. (1991). Inhibition of rat mammary gland chemical carcinogenesis by dietary dehydroepiandrosterone or a fluorinated analogue of dehydroepiandrosterone.. PubMed. 51(2). 481–6. 66 indexed citations

Mehta, Rajendra G. & R C Moon. (1991). Characterization of effective chemopreventive agents in mammary gland in vitro using an initiation-promotion protocol.. PubMed. 11(2). 593–6. 85 indexed citations

Dowlatshahi, Kambiz, Ranjan Mehta, Cathy F. Thomas, Nancy Dinger, & R C Moon. (1989). Therapeutic effect of N-(4-hydroxyphenyl)retinamide on N-methyl-N-nitrosourea-induced rat mammary cancer. Cancer Letters. 47(3). 187–192. 39 indexed citations

Mehta, Rajendra G., et al.. (1988). Metabolism of the chemopreventive retinoid N-(4-hydroxyphenyl)retinamide by mammary gland in organ culture. Biochemical Journal. 256(2). 579–584. 22 indexed citations

10.

McCormick, David L., et al.. (1988). Effects of pretreatment with the retinoid N-(4-hydroxyphenyl)-all-trans-retinamide and phenobarbital on the disposition and metabolism of N-(4-hydroxyphenyl)-all-trans-retinamide in mice.. Drug Metabolism and Disposition. 16(6). 783–788. 8 indexed citations

11.

Becci, Peter J., et al.. (1981). N-butyl-n-(4-hydroxybutyl)nitrosamine induced urinary bladder cancer in the mouse: effect of total carcinogen dose and dose schedule.. The Mouseion at the JAXlibrary (Jackson Laboratory). 77. 6 indexed citations

12.

Grubbs, Clinton J. & R C Moon. (1975). Effect of age and parity upon the uptake of 9,10-dimethyl-1,2-benzanthracene-9-14C by mammary parenchymal cells of the rat. British Journal of Cancer. 31(2). 189–196. 3 indexed citations

13.

Moon, R C, et al.. (1973). Effect of increasing doses of estrogen and progesterone on mammary carcinogenesis in the rat. European Journal of Cancer (1965). 9(7). 483–486. 27 indexed citations

14.

Moon, R C, et al.. (1967). Effect of nursing and litter size on growth of 7,12-dimethylbenz(a)anthracene (DMBA)-induced rat mammary tumors.. British Journal of Cancer. 21(3). 586–591. 4 indexed citations

15.

Moon, R C, et al.. (1965). Effect of Pregnancy and Lactation on Growth of Mammary Tumours Induced by 7,12-Dimethylbenz(a)anthracene (DMBA). British Journal of Cancer. 19(1). 160–166. 57 indexed citations

16.

Moon, R C. (1960). Hormones and mammary gland growth.. Journal of Animal Science. 19(4). 1 indexed citations

17.

Moon, R C, et al.. (1960). Thyroid Hormone and Mammary Gland Growth in the Rat.. Experimental Biology and Medicine. 103(1). 149–151. 13 indexed citations

18.

Moon, R C, et al.. (1959). A Mode of Action for Thyroid Inhibition by Reserpine.. Experimental Biology and Medicine. 102(1). 134–136. 9 indexed citations

19.

Moon, R C, et al.. (1959). Effect of Reserpine on Oxytocin and Lactogen Discharge in Lactating Rats.. Experimental Biology and Medicine. 101(2). 332–335. 9 indexed citations

20.

Moon, R C, et al.. (1959). Effect of Reserpine on Thyroid Activity in Rats.. Experimental Biology and Medicine. 100(4). 679–681. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact